story of the week
Ripasudil May Be a Beneficial Addition to Maximum Medical Therapy in Glaucoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Glaucoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
J. Glaucoma 2016 Sep 21;[EPub Ahead of Print], H Inazaki, S Kobayashi, Y Anzai, H Satoh, S Sato, M Inoue, S Yamane, K KadonosonoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.